- Home
- LBTYK vs TWST Comparison
LBTYK vs TWST Comparison
Compare LBTYK & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LBTYK | TWST |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | | US |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.0B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | LBTYK | TWST |
|---|---|---|
| Price | $12.72 | $54.51 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $48.75 |
| AVG Volume (30 Days) | 1.1M | ★ 1.5M |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $376,572,000.00 |
| Revenue This Year | $15.50 | $18.89 |
| Revenue Next Year | $2.11 | $15.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $9.21 | $23.30 |
| 52 Week High | $13.12 | $57.88 |
Technical Indicators
Market Signals| Indicator | LBTYK | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 71.23 | 73.71 |
| Support Level | $10.73 | $46.96 |
| Resistance Level | $11.76 | $50.65 |
| Average True Range (ATR) | 0.45 | 3.13 |
| MACD | 0.08 | 0.41 |
| Stochastic Oscillator | 84.54 | 82.41 |
Price Performance
Historical ComparisonAbout LBTYK Liberty Global Ltd. Class C
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.